The use of droperidol before and after the Food and Drug Administration black box warning: a survey of the members of the Society of Ambulatory Anesthesia
Authors:
- Ashraf S. HabibAHAshraf S. Habib
- Tong J. GanTGTong J. Gan
- 1 February 2008
- journal article
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 20 (1) , 35-39
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prolongation of QTc Interval after Postoperative Nausea and Vomiting Treatment by Droperidol or OndansetronAnesthesiology, 2005
- Effect of Low-dose Droperidol on the QT Interval during and after General AnesthesiaAnesthesiology, 2005
- A Model for Evaluating Droperidol???s Effect on the Median QTc IntervalAnesthesia & Analgesia, 2004
- Principles of Successful Sample SurveysAnesthesiology, 2003
- Consensus Guidelines for Managing Postoperative Nausea and VomitingAnesthesia & Analgesia, 2003
- Food and Drug Administration Black Box Warning on the Perioperative Use of Droperidol: A Review of the CasesAnesthesia & Analgesia, 2003
- Droperidol: A Cost-Effective Antiemetic for Over Thirty YearsAnesthesia & Analgesia, 2002
- FDA “Black Box” Warning Regarding Use of Droperidol for Postoperative Nausea and Vomiting: Is It Justified?Anesthesiology, 2002
- A Comparison of Costs and Efficacy of Ondansetron and Droperidol as Prophylactic Antiemetic Therapy for Elective Outpatient Gynecologic ProceduresAnesthesia & Analgesia, 1996
- Transdermal Scopolamine Reduces Nausea and Vomiting After Outpatient LaparoscopyAnesthesiology, 1990